Edén C S, Hagberg L, Hanson L A, Korhonen T, Leffler H, Olling S
Ciba Found Symp. 1981;80:161-87. doi: 10.1002/9780470720639.ch11.
In individuals prone to urinary tract infections the intestine is colonized by E. Coli strains that possess a combination of properties determining virulence. Such an E. coli strain may colonize the vaginal and periurethral area and ascend the urinary tract. The ability to attach to the mucosal surface is thought to be essential for E. coli to colonize and to remain in the urinary tract. Most E. coli from patients with urinary tract infection show one or both of two adherence properties. One may depend on the recognition by type 1 fimbriae of mannose-containing residues in the urinary slime. It is measured as mannose-sensitive haemagglutination and is found on most E. coli strains. The second adherence property is detected as attachment to human urinary tract epithelial cells and as mannose-resistant agglutination of human erythrocytes. This may depend on the recognition of globo-series glycolipids in the epithelial cell surface. Possession of this adherence factor is strongly related to virulence. Most strains from patients with acute pyelonephritis and cystitis have this property but it is rare in strains from patients with asymptomatic bacteriuria and strains from normal faeces. Local antibodies may interfere with bacterial attachment, thus possibly preventing the colonization that precedes urinary tract infection or modifying an established infection. Vaginal antibodies are known to coat E. coli from the stools. Antibodies in the urine of patients with acute pyelonephritis inhibit attachment of the infecting strain to uroepithelial cells. Antibodies directed against several bacterial surface structures, for example O antigen and fimbriae, are likely to inhibit attachment by steric hindrance or agglutination. The role of antibodies in adhesion-mediating structure such as fimbriae in susceptibility to and the outcome of human urinary tract infection remains to be investigated.
在易患尿路感染的个体中,肠道被具有决定毒力的多种特性组合的大肠杆菌菌株定植。这样的大肠杆菌菌株可能定植于阴道和尿道周围区域,并上行至尿路。附着于粘膜表面的能力被认为是大肠杆菌在尿路定植并留存的关键。大多数来自尿路感染患者的大肠杆菌表现出两种黏附特性中的一种或两种。一种可能取决于1型菌毛对尿黏液中含甘露糖残基的识别。它通过甘露糖敏感血凝反应来测定,在大多数大肠杆菌菌株中都能发现。第二种黏附特性表现为对人尿道上皮细胞的附着以及对人红细胞的甘露糖抗性凝集。这可能取决于对上皮细胞表面球系列糖脂的识别。拥有这种黏附因子与毒力密切相关。大多数来自急性肾盂肾炎和膀胱炎患者的菌株具有这种特性,但在无症状菌尿患者的菌株和正常粪便中的菌株中很少见。局部抗体可能会干扰细菌附着,从而有可能预防在尿路感染之前的定植或改变已有的感染。已知阴道抗体可包裹来自粪便的大肠杆菌。急性肾盂肾炎患者尿液中的抗体可抑制感染菌株对尿道上皮细胞的附着。针对几种细菌表面结构(例如O抗原和菌毛)的抗体可能通过空间位阻或凝集作用来抑制附着。抗体在诸如菌毛等黏附介导结构中对人类尿路感染易感性和结局的作用仍有待研究。